{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T06:29:27Z","timestamp":1774506567153,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,4,25]],"date-time":"2016-04-25T00:00:00Z","timestamp":1461542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2016,4,25]],"date-time":"2016-04-25T00:00:00Z","timestamp":1461542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1038\/npp.2016.60","type":"journal-article","created":{"date-parts":[[2016,4,25]],"date-time":"2016-04-25T11:01:39Z","timestamp":1461582099000},"page":"2647-2657","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Opioid Antagonists and the A118G Polymorphism in the \u03bc-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype"],"prefix":"10.1038","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4044-1719","authenticated-orcid":false,"given":"Hisham","family":"Ziauddeen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liam J","family":"Nestor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naresh","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Dodds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep J","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam R","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhopinder K","family":"Sarai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kay","family":"Maltby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Disala","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liling","family":"Warren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise K","family":"Hosking","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn","family":"Waterworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Korzeniowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beta","family":"Win","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duncan B","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshmi","family":"Vasist Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul C","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward T","family":"Bullmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,25]]},"reference":[{"key":"BFnpp201660_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1001\/archpsyc.65.2.135","volume":"65","author":"RF Anton","year":"2008","unstructured":"Anton RF, Oroszi G, O'Malley S, Couper D, Swift R, Pettinati H et al (2008). An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen Psychiatry 65: 135\u2013144.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp201660_CR2","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1111\/j.1530-0277.2012.01807.x","volume":"36","author":"RF Anton","year":"2012","unstructured":"Anton RF, Voronin KK, Randall PK, Myrick H, Tiffany A (2012). Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes. Alcohol Clin Exp Res 36: 2000\u20132007.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFnpp201660_CR3","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.drugalcdep.2005.11.024","volume":"83","author":"A Arias","year":"2006","unstructured":"Arias A, Feinn R, Kranzler HR (2006). Association of an Asn40Asp (A118G) polymorphism in the \u03bc-opioid receptor gene with substance dependence: a meta- analysis. Drug Alcohol Depend 83: 262\u2013268.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp201660_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.biopsych.2009.07.026","volume":"67","author":"CS Barr","year":"2010","unstructured":"Barr CS, Chen SA, Schwandt ML, Lindell SG, Sun H, Suomi SJ et al (2010). Suppression of alcohol preference by naltrexone in the rhesus macaque: a critical role of genetic variation at the \u03bc-opioid receptor gene locus. Biol Psychiatry 67: 78\u201380.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201660_CR5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1001\/archpsyc.64.3.369","volume":"64","author":"CS Barr","year":"2007","unstructured":"Barr CS, Schwandt M, Lindell SG, Chen SA, Goldman D, Suomi SJ et al (2007). Association of a functional polymorphism in the \u03bc-opioid receptor gene with alcohol response and consumption in male rhesus macaques. Arch Gen Psychiatry 64: 369\u2013376.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp201660_CR6","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","volume":"56","author":"AT Beck","year":"1988","unstructured":"Beck AT, Epstein N, Brown G, Steer RA (1988). An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56: 893\u2013897.","journal-title":"J Consult Clin Psychol"},{"key":"BFnpp201660_CR7","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"AT Beck","year":"1961","unstructured":"Beck AT, Ward CH, Mendelson J, Mock J, Erbaugh J (1961). An inventory for measuring depression. Arch Gen Psychiatry 4: 561\u2013571.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp201660_CR8","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1471-4159.2004.02340.x","volume":"89","author":"A Beyer","year":"2004","unstructured":"Beyer A, Koch T, Schr\u00f6der H, Schulz S, H\u00f6llt V (2004). Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor. J Neurochem 89: 553\u2013560.","journal-title":"J Neurochem"},{"key":"BFnpp201660_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.2044-8341.1974.tb02285.x","volume":"47","author":"A Bond","year":"1974","unstructured":"Bond A, Lader M (1974). The use of analogue scales in rating subjective feelings. Br J Med Psychol 47: 211\u2013218.","journal-title":"Br J Med Psychol"},{"key":"BFnpp201660_CR10","doi-asserted-by":"publisher","first-page":"9608","DOI":"10.1073\/pnas.95.16.9608","volume":"95","author":"C Bond","year":"1998","unstructured":"Bond C, LaForge KS, Tian MT, Melia D, Zhang SW, Borg L et al (1998). Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: Possible implications for opiate addiction. Proc Natl Acad Sci USA 95: 9608\u20139613.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp201660_CR11","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.biopsych.2012.10.022","volume":"73","author":"VC Cambridge","year":"2012","unstructured":"Cambridge VC, Ziauddeen H, Nathan PJ, Subramaniam N, Dodds C, Chamberlain SR et al (2012). Neural and behavioral effects of a novel mu opioid receptor antagonist in binge-eating obese people. Biol Psychiatry 73: 887\u2013894.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201660_CR12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00213-012-2778-x","volume":"224","author":"SR Chamberlain","year":"2012","unstructured":"Chamberlain SR, Mogg K, Bradley BP, Koch A, Dodds CM, Tao WX et al (2012). Effects of mu opioid receptor antagonism on cognition in obese binge-eating individuals. Psychopharmacology 224: 501\u2013509.","journal-title":"Psychopharmacology"},{"key":"BFnpp201660_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2011.10.012","volume":"123","author":"D Chen","year":"2012","unstructured":"Chen D, Liu L, Xiao Y, Peng Y, Yang C, Wang Z (2012). Ethnic-specific meta-analyses of association between the OPRM1 A118G polymorphism and alcohol dependence among Asians and Caucasians. Drug Alcohol Depend 123: 1\u20136.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp201660_CR14","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1038\/npp.2011.99","volume":"36","author":"ED Claus","year":"2011","unstructured":"Claus ED, Ewing SWF, Filbey FM, Sabbineni A, Hutchison KE (2011). Identifying neurobiological phenotypes associated with alcohol use disorder severity. Neuropsychopharmacology 36: 2086\u20132096.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201660_CR15","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1038\/ijo.2010.276","volume":"35","author":"C Davis","year":"2011","unstructured":"Davis C, Zai C, Levitan RD, Kaplan AS, Carter JC, Reid-Westoby C et al (2011). Opiates, overeating and obesity: a psychogenetic analysis. Int J Obes (Lond) 35: 1347\u20131354.","journal-title":"Int J Obes (Lond)"},{"key":"BFnpp201660_CR16","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/oby.2009.52","volume":"17","author":"CA Davis","year":"2009","unstructured":"Davis CA, Levitan RD, Reid C, Carter JC, Kaplan AS, Patte KA et al (2009). Dopamine for \u2018wanting\u2019 and opioids for \u2018liking\u2019: a comparison of obese adults with and without binge eating. Obesity (Silver Spring) 17: 1220\u20131225.","journal-title":"Obesity (Silver Spring)"},{"key":"BFnpp201660_CR17","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/sj.npp.1301513","volume":"33","author":"FM Filbey","year":"2007","unstructured":"Filbey FM, Claus E, Audette AR, Niculescu M, Banich MT, Tanabe J et al (2007). Exposure to the taste of alcohol elicits activation of the mesocorticolimbic neurocircuitry. Neuropsychopharmacology 33: 1391\u20131401.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201660_CR18","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/j.1530-0277.2008.00692.x","volume":"32","author":"FM Filbey","year":"2008","unstructured":"Filbey FM, Ray L, Smolen A, Claus ED, Audette A, Hutchison KE (2008). Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes. Alcohol Clin Exp Res 32: 1113\u20131123.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFnpp201660_CR19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1530-0277.2007.00339.x","volume":"31","author":"J Gelernter","year":"2007","unstructured":"Gelernter J, Gueorguieva R, Kranzler HR, Zhang H, Cramer J, Rosenheck R et al (2007). Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study. Alcohol Clin Exp Res 31: 555\u2013563.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFnpp201660_CR20","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1038\/npp.2012.128","volume":"37","author":"C Giuliano","year":"2012","unstructured":"Giuliano C, Robbins TW, Nathan PJ, Bullmore ET, Everitt BJ (2012). Inhibition of opioid transmission at the \u03bc-opioid receptor prevents both food seeking and binge-like eating. Neuropsychopharmacology 37: 2643\u20132652.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201660_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00213-012-2949-9","volume":"227","author":"C Giuliano","year":"2013","unstructured":"Giuliano C, Robbins TW, Wille DR, Bullmore ET, Everitt BJ (2013). Attenuation of cocaine and heroin seeking by \u03bc-opioid receptor antagonism. Psychopharmacology 227: 137\u2013147.","journal-title":"Psychopharmacology"},{"key":"BFnpp201660_CR22","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1038\/npp.2015.152","volume":"40","author":"C Giuliano","year":"2015","unstructured":"Giuliano C, Goodlett CR, Economidou D, Garc\u00eda-Pardo MP, Belin D, Robbins TW et al (2015). The novel \u03bc-opioid receptor antagonist GSK1521498 decreases both alcohol seeking and drinking: evidence from a new preclinical model of alcohol seeking. Neuropsychopharmacology 40: 2981\u20132992.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201660_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/adb.12165","volume":"21","author":"CS Hendershot","year":"2016","unstructured":"Hendershot CS, Claus ED, Ramchandani VA (2016). Associations of OPRM1 A118G and alcohol sensitivity with intravenous alcohol self-administration in young adults. Addiction Biology 21: 125\u2013135.","journal-title":"Addiction Biology"},{"key":"BFnpp201660_CR24","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/ajmg.b.10054","volume":"118B","author":"CA Hernandez-Avila","year":"2003","unstructured":"Hernandez-Avila CA, Wand G, Luo X, Gelernter J, Kranzler HR (2003). Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1). Am J Med Genet B Neuropsychiatr Genet 118B(1): 60\u201365.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"BFnpp201660_CR25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1042\/BJ20111050","volume":"441","author":"P Huang","year":"2012","unstructured":"Huang P, Chen C, Mague SD, Blendy JA, Liu-Chen L-Y (2012). A common single nucleotide polymorphism A118G of the \u03bc opioid receptor alters its N-glycosylation and protein stability. Biochem J 441: 379\u2013386.","journal-title":"Biochem J"},{"key":"BFnpp201660_CR26","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1097\/ALN.0000000000000405","volume":"121","author":"IC Hwang","year":"2014","unstructured":"Hwang IC, Park J-Y, Myung S-K, Ahn HY, Fukuda K-I, Liao Q (2014). OPRM1 A118G gene variant and postoperative opioid requirement: a systematic review and meta-analysis. Anesthesiology 121: 825\u2013834.","journal-title":"Anesthesiology"},{"key":"BFnpp201660_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1124\/jpet.111.180943","volume":"339","author":"DM Ignar","year":"2011","unstructured":"Ignar DM, Goetz AS, Noble KN, Carballo LH, Stroup AE, Fisher JC et al (2011). Regulation of ingestive behaviors in the rat by GSK1521498, a novel -opioid receptor-selective inverse agonist. J Pharmacol Exp Ther 339: 24\u201334.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp201660_CR28","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00213-014-3666-3","volume":"232","author":"E Kelly","year":"2015","unstructured":"Kelly E, Mundell SJ, Sava A, Roth AL, Felici A, Maltby K et al (2015). The opioid receptor pharmacology of GSK1521498 compared to other ligands with differential effects on compulsive reward-related behaviours. Psychopharmacology 232: 305\u2013314.","journal-title":"Psychopharmacology"},{"key":"BFnpp201660_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s002130050156","volume":"129","author":"AC King","year":"1997","unstructured":"King AC, Volpicelli JR, Frazer A, O'Brien CP (1997). Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence. Psychopharmacology 129: 15\u201322.","journal-title":"Psychopharmacology"},{"key":"BFnpp201660_CR30","doi-asserted-by":"publisher","first-page":"10847","DOI":"10.1073\/pnas.0901800106","volume":"106","author":"SD Mague","year":"2009","unstructured":"Mague SD, Isiegas C, Huang P, Liu-Chen L-Y, Lerman C, Blendy JA (2009). Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior. Proc Natl Acad Sci USA 106: 10847\u201310852.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp201660_CR31","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/S1053-8119(03)00169-1","volume":"19","author":"JA Maldjian","year":"2003","unstructured":"Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH (2003). An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 19: 1233\u20131239.","journal-title":"Neuroimage"},{"key":"BFnpp201660_CR32","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1530-0277.1993.tb00739.x","volume":"17","author":"CS Martin","year":"1993","unstructured":"Martin CS, Earleywine M, Musty RE, Perrine MW, Swift RM (1993). Development and validation of the Biphasic Alcohol Effects Scale. Alcohol Clin Exp Res 17: 140\u2013146.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFnpp201660_CR33","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/S0893-133X(02)00368-8","volume":"27","author":"BJ Mason","year":"2002","unstructured":"Mason BJ, Goodman AM, Dixon RM, Hameed MH, Hulot T, Wesnes K et al (2002). A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone. Neuropsychopharmacology 27: 596\u2013606.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201660_CR34","volume-title":"Profile of Mood States technical update","author":"DM McNair","year":"2005","unstructured":"McNair DM, Heuchert JWP (2005) Profile of Mood States technical update. North Tonawanda, NY: Multi-Health Systems."},{"key":"BFnpp201660_CR35","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1177\/0091270011421785","volume":"52","author":"PJ Nathan","year":"2012","unstructured":"Nathan PJ, Bush MA, Tao WX, Koch A, Davies KM, Maltby K et al (2012). Multiple-dose safety, pharmacokinetics, and pharmacodynamics of the \u03bc-opioid receptor inverse agonist GSK1521498. J Clin Pharmacol 52: 1456\u20131467.","journal-title":"J Clin Pharmacol"},{"key":"BFnpp201660_CR36","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1038\/sj.npp.1300219","volume":"28","author":"DW Oslin","year":"2003","unstructured":"Oslin DW, Berrettini W, Kranzler HR, Pettinati H, Gelernter J, Volpicelli JR et al (2003). A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 28: 1546\u20131552.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201660_CR37","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1001\/jamapsychiatry.2014.3053","volume":"72","author":"DW Oslin","year":"2015","unstructured":"Oslin DW, Leong SH, Lynch KG, Berrettini W, O'Brien CP, Gordon AJ et al (2015). Naltrexone vs placebo for the treatment of alcohol dependence: a randomized clinical trial. JAMA Psychiatry 72: 430\u2013437.","journal-title":"JAMA Psychiatry"},{"key":"BFnpp201660_CR38","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1176\/ajp.2007.164.7.1035","volume":"164","author":"K Posner","year":"2007","unstructured":"Posner K, Oquendo M, Gould M, Stanley B, Davies M (2007). Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA\u2019s pediatric suicidal risk analysis of antidepressants. Am J Psychiatry 164: 1035\u20131043.","journal-title":"Am J Psychiatry"},{"key":"BFnpp201660_CR39","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/mp.2011.29","volume":"16","author":"EA Rabiner","year":"2011","unstructured":"Rabiner EA, Beaver J, Makwana A, Searle G, Long C, Nathan PJ et al (2011). Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans. Mol Psychiatry 16: 826\u2013785.","journal-title":"Mol Psychiatry"},{"key":"BFnpp201660_CR40","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/mp.2010.56","volume":"16","author":"VA Ramchandani","year":"2011","unstructured":"Ramchandani VA, Umhau J, Pavon FJ, Ruiz-Velasco V, Margas W, Sun H et al (2011). A genetic determinant of the striatal dopamine response to alcohol in men. Mol Psychiatry 16: 809\u2013817.","journal-title":"Mol Psychiatry"},{"key":"BFnpp201660_CR41","doi-asserted-by":"publisher","first-page":"E116","DOI":"10.1111\/j.1530-0277.2012.01916.x","volume":"37","author":"LA Ray","year":"2012","unstructured":"Ray LA, Bujarski S, Mackillop J, Courtney KE, Monti PM, Miotto K (2012). Subjective response to alcohol among alcohol-dependent individuals: effects of the mu-opioid receptor (OPRM1) gene and alcoholism severity. Alcohol Clin Exp Res 37(Suppl 1): E116\u2013E124.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFnpp201660_CR42","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/alcalc\/agt183","volume":"49","author":"LA Ray","year":"2014","unstructured":"Ray LA, Bujarski S, Squeglia LM, Ashenhurst JR, Anton RF (2014). Interactive effects of OPRM1 and DAT1 genetic variation on subjective responses to alcohol. Alcohol Alcohol 49: 261\u2013270.","journal-title":"Alcohol Alcohol"},{"key":"BFnpp201660_CR43","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/acer.12136","volume":"38","author":"LA Ray","year":"2013","unstructured":"Ray LA, Courtney KE, Hutchison KE, Mackillop J, Galvan A, Ghahremani DG (2013). Initial evidence that OPRM1 genotype moderates ventral and dorsal striatum functional connectivity during alcohol cues. Alcohol Clin Exp Res 38: 78\u201389.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFnpp201660_CR44","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1097\/01.ALC.0000148114.34000.B9","volume":"28","author":"LA Ray","year":"2004","unstructured":"Ray LA, Hutchison KE (2004). A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans. Alcohol Clin Exp Res 28: 1789\u20131795.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFnpp201660_CR45","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1001\/archpsyc.64.9.1069","volume":"64","author":"LA Ray","year":"2007","unstructured":"Ray LA, Hutchison KE (2007). Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. Arch Gen Psychiatry 64: 1069\u20131077.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp201660_CR46","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1007\/s00213-015-3995-x","volume":"232","author":"TL Ripley","year":"2015","unstructured":"Ripley TL, Sanchez-Roige S, Bullmore ET, Mugnaini M, Maltby K, Miller SR et al (2015). The novel mu-opioid antagonist, GSK1521498, reduces ethanol consumption in C57BL\/6J mice. Psychopharmacology 232: 3431\u20133441.","journal-title":"Psychopharmacology"},{"key":"BFnpp201660_CR47","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/alcalc\/agt050","volume":"48","author":"N Rouvinen-Lagerstrom","year":"2013","unstructured":"Rouvinen-Lagerstrom N, Lahti J, Alho H, Kovanen L, Aalto M, Partonen T et al (2013). Opioid receptor gene (OPRM1) polymorphism A118G: lack of association in Finnish populations with alcohol dependence or alcohol consumption. Alcohol Alcohol 48: 519\u2013525.","journal-title":"Alcohol Alcohol"},{"key":"BFnpp201660_CR48","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/npp.2012.195","volume":"38","author":"JP Schacht","year":"2013","unstructured":"Schacht JP, Anton RF, Voronin KE, Randall PK, Li X, Henderson S et al (2013). Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues. Neuropsychopharmacology 38: 414\u2013422.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201660_CR49","doi-asserted-by":"publisher","first-page":"242","DOI":"10.15288\/jsa.1980.41.242","volume":"41","author":"MA Schuckit","year":"1980","unstructured":"Schuckit MA (1980). Self-rating of alcohol intoxication by young men with and without family histories of alcoholism. J Stud Alcohol 41: 242\u2013249.","journal-title":"J Stud Alcohol"},{"key":"BFnpp201660_CR50","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10519-015-9737-3","volume":"46","author":"T-H Schwantes-An","year":"2016","unstructured":"Schwantes-An T-H, Zhang J, Chen L-S, Hartz SM, Culverhouse RC, Chen X et al (2016). Association of the OPRM1 variant rs1799971 (A118G) with non-specific liability to substance dependence in a collaborative de novo meta-analysis of European-ancestry cohorts. Behav Genet 46: 151\u2013169.","journal-title":"Behav Genet"},{"key":"BFnpp201660_CR51","first-page":"34","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E et al (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20): 22-33; quiz 34\u201357.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp201660_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1530-0277.2006.00258.x","volume":"31","author":"E van den Wildenberg","year":"2007","unstructured":"van den Wildenberg E, Wiers RW, Dessers J, Janssen RGJH, Lambrichs EH, Smeets HJM et al (2007). A functional polymorphism of the \u03bc-opioid receptor gene (OPRM1) influences cue-induced craving for alcohol in male heavy drinkers. Alcohol Clin Exp Res 31: 1\u201310.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFnpp201660_CR53","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1601-183X.2008.00454.x","volume":"8","author":"RW Wiers","year":"2009","unstructured":"Wiers RW, Rinck M, Dictus M, van den Wildenberg E (2009). Relatively strong automatic appetitive action-tendencies in male carriers of the OPRM1 G-allele. Genes Brain Behav 8: 101\u2013106.","journal-title":"Genes Brain Behav"},{"key":"BFnpp201660_CR54","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0149-7634(02)00041-6","volume":"26","author":"MR Yeomans","year":"2002","unstructured":"Yeomans MR, Gray RW (2002). Opioid peptides and the control of human ingestive behaviour. Neurosci Biobehav Rev 26: 713\u2013728.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp201660_CR55","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/mp.2012.154","volume":"18","author":"H Ziauddeen","year":"2013","unstructured":"Ziauddeen H, Chamberlain SR, Nathan PJ, Koch A, Maltby K, Bush M et al (2013a). Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism study in binge-eating obese subjects. Mol Psychiatry 18: 1287\u20131293.","journal-title":"Mol Psychiatry"},{"key":"BFnpp201660_CR56","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/jcph.110","volume":"53","author":"H Ziauddeen","year":"2013","unstructured":"Ziauddeen H, Nathan PJ, Dodds C, Maltby K, Miller SR, Waterworth D et al (2013b). The effects of alcohol on the pharmacokinetics and pharmacodynamics of the selective mu-opioid receptor antagonist GSK1521498 in healthy subjects. J Clin Pharmacol 53: 1078\u20131090.","journal-title":"J Clin Pharmacol"}],"updated-by":[{"DOI":"10.1038\/npp.2017.287","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T00:00:00Z","timestamp":1518134400000}}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp201660.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201660","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201660.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T19:27:48Z","timestamp":1692300468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp201660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,25]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["BFnpp201660"],"URL":"https:\/\/doi.org\/10.1038\/npp.2016.60","relation":{"erratum":[{"id-type":"doi","id":"10.1038\/npp.2017.287","asserted-by":"object"}]},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,25]]},"assertion":[{"value":"22 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}